Bulk Manufacturer of Controlled Substances Application: Nanosyn Inc., 65608 [2022-23609]

Download as PDF 65608 Federal Register / Vol. 87, No. 209 / Monday, October 31, 2022 / Notices minutes or the time taken to prepare each response). If additional information is required contact: Robert Houser, Department Clearance Officer, Policy and Planning Staff, Office of the Chief Information Officer, Justice Management Division, United States Department of Justice, Two Constitution Square, 145 N Street NE, 3.E–206, Washington, DC 20530. Dated: October 25, 2022. Robert Houser, Department Clearance Officer, Policy and Planning Staff, Office of the Chief Information Officer, U.S. Department of Justice. [FR Doc. 2022–23591 Filed 10–28–22; 8:45 am] BILLING CODE 4410–FY–P DEPARTMENT OF JUSTICE I 9652 9801 II III The company is a contract manufacturer. At the request of the company’s customers, it manufactures derivatives of the above controlled substances in bulk form. No other activities for these drug codes are authorized for this registration. BILLING CODE 4410–09–P Bulk Manufacturer of Controlled Substances Application: Nanosyn Inc. Drug Enforcement Administration, Justice. ACTION: Notice of application. AGENCY: Jkt 259001 DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA–1109] Nanoysn Inc. has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information. DATES: Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may submit electronic comments on or objections to the issuance of the proposed registration on or before December 30, 2022. Such persons may also file a written request for a hearing on the application on or before December 30, 2022. ADDRESSES: The Drug Enforcement Administration requires that all comments be submitted electronically through the Federal eRulemaking Portal, which provides the ability to type short comments directly into the comment field on the web page or attach a file for lengthier comments. Please go to https://www.regulations.gov and follow the online instructions at that site for submitting comments. Upon submission of your comment, you will receive a Comment Tracking Number. Please be aware that submitted comments are not instantaneously available for public view on https://www.regulations.gov. If you have received a Comment Tracking Number, your comment has been successfully submitted and there is no need to resubmit the same comment. SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this SUMMARY: khammond on DSKJM1Z7X2PROD with NOTICES Oxymorphone ............... Fentanyl ........................ Schedule [FR Doc. 2022–23609 Filed 10–28–22; 8:45 am] [Docket No. DEA–1107] 17:15 Oct 28, 2022 Drug code Controlled substance Kristi O’Malley, Assistant Administrator. Drug Enforcement Administration VerDate Sep<11>2014 is notice that on September 2, 2022, Nanosyn Inc., 3331 Industrial Drive, Suite B, Santa Rosa, California 95403– 2062, applied to be registered as a bulk manufacturer of the following basic class(es) of controlled substance(s): Bulk Manufacturer of Controlled Substances Application: Noramco Drug Enforcement Administration, Justice. ACTION: Notice of application. AGENCY: Noramco has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information. DATES: Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may submit electronic comments on or objections to the issuance of the proposed registration on or before December 30, 2022. Such persons may also file a written request for a hearing on the application on or before December 30, 2022. ADDRESSES: The Drug Enforcement Administration requires that all comments be submitted electronically through the Federal eRulemaking Portal, which provides the ability to type short comments directly into the comment field on the web page or attach a file for lengthier comments. Please go to https://www.regulations.gov and follow the online instructions at that site for submitting comments. Upon submission of your comment, you will receive a Comment Tracking Number. Please be aware that submitted comments are not instantaneously available for public view on https://www.regulations.gov. If SUMMARY: PO 00000 Frm 00041 Fmt 4703 Sfmt 9990 you have received a Comment Tracking Number, your comment has been successfully submitted and there is no need to resubmit the same comment. In accordance with 21 CFR 1301.33(a), this is notice that on September 29, 2022, Noramco, 500 Swedes Landing Road, Wilmington, Delaware 19801–4417, applied to be registered as a bulk manufacturer of the following basic class(es) of controlled substance(s): SUPPLEMENTARY INFORMATION: Controlled substance Gamma Hydroxybutyric Acid. Marihuana ..................... Tetrahydrocannabinols Codeine-N-oxide ........... Dihydromorphine .......... Hydromorphinol ............ Morphine-N-oxide ......... Amphetamine ............... Lisdexamfetamine ........ Methylphenidate ........... Nabilone ....................... Phenylacetone .............. Codeine ........................ Dihydrocodeine ............. Oxycodone ................... Hydromorphone ............ Hydrocodone ................ Morphine ....................... Oripavine ...................... Thebaine ....................... Opium extracts ............. Opium fluid extract ....... Opium, tincture ............. Opium, powdered ......... Opium, granulated ........ Oxymorphone ............... Noroxymorphone .......... Tapentadol .................... Drug code Schedule 2010 I 7360 7370 9053 9145 9301 9307 1100 1205 1724 7379 8501 9050 9120 9143 9150 9193 9300 9330 9333 9610 9620 9630 9639 9640 9652 9668 9780 I I I I I I II II II II II II II II II II II II II II II II II II II II II The company plans to bulk manufacture the listed controlled substances as an Active Pharmaceutical Ingredient (API) for supply to its customers. In reference to drug codes 7360 (Marihuana), and 7370 (Tetrahydrocannabinols), the company plans to bulk manufacture these drugs as synthetic. No other activities for these drug codes are authorized for this registration. Kristi O’Malley, Assistant Administrator. [FR Doc. 2022–23614 Filed 10–28–22; 8:45 am] BILLING CODE 4410–09–P E:\FR\FM\31OCN1.SGM 31OCN1

Agencies

[Federal Register Volume 87, Number 209 (Monday, October 31, 2022)]
[Notices]
[Page 65608]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-23609]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-1107]


Bulk Manufacturer of Controlled Substances Application: Nanosyn 
Inc.

AGENCY: Drug Enforcement Administration, Justice.

ACTION: Notice of application.

-----------------------------------------------------------------------

SUMMARY: Nanoysn Inc. has applied to be registered as a bulk 
manufacturer of basic class(es) of controlled substance(s). Refer to 
SUPPLEMENTARY INFORMATION listed below for further drug information.

DATES: Registered bulk manufacturers of the affected basic class(es), 
and applicants therefore, may submit electronic comments on or 
objections to the issuance of the proposed registration on or before 
December 30, 2022. Such persons may also file a written request for a 
hearing on the application on or before December 30, 2022.

ADDRESSES: The Drug Enforcement Administration requires that all 
comments be submitted electronically through the Federal eRulemaking 
Portal, which provides the ability to type short comments directly into 
the comment field on the web page or attach a file for lengthier 
comments. Please go to https://www.regulations.gov and follow the 
online instructions at that site for submitting comments. Upon 
submission of your comment, you will receive a Comment Tracking Number. 
Please be aware that submitted comments are not instantaneously 
available for public view on https://www.regulations.gov. If you have 
received a Comment Tracking Number, your comment has been successfully 
submitted and there is no need to resubmit the same comment.

SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this 
is notice that on September 2, 2022, Nanosyn Inc., 3331 Industrial 
Drive, Suite B, Santa Rosa, California 95403-2062, applied to be 
registered as a bulk manufacturer of the following basic class(es) of 
controlled substance(s):

------------------------------------------------------------------------
                                           Drug
          Controlled substance             code          Schedule
------------------------------------------------------------------------
Oxymorphone............................     9652  II
Fentanyl...............................     9801  II
------------------------------------------------------------------------

    The company is a contract manufacturer. At the request of the 
company's customers, it manufactures derivatives of the above 
controlled substances in bulk form. No other activities for these drug 
codes are authorized for this registration.

Kristi O'Malley,
Assistant Administrator.
[FR Doc. 2022-23609 Filed 10-28-22; 8:45 am]
BILLING CODE 4410-09-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.